OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integration and the risk of liver cancer—Is there a real risk?
Aradhana Kasimsetty, Denise E. Sabatino
Journal of Viral Hepatitis (2024) Vol. 31, Iss. S1, pp. 26-34
Open Access | Times Cited: 13

Showing 13 citing articles:

Twenty-Year Survival Analysis of Adeno-Associated Virus Vector Serotype 2-Mediated Gene Therapy to the Central Nervous System for CLN2 Disease
Dolan Sondhi, Stephen M. Kaminsky, Jonathan B. Rosenberg, et al.
Human Gene Therapy (2025)
Closed Access

Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy
Pasqualina Colella
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 6, pp. 703-719
Closed Access | Times Cited: 3

Pilocytic Astrocytoma in a Child with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec
Dorothea Holzwarth, Gabriele Calaminus, Johannes Friese, et al.
Molecular Therapy (2025)
Closed Access

Haemophilia
Pratima Chowdary, Manuel Carção, Gili Kenet, et al.
The Lancet (2025) Vol. 405, Iss. 10480, pp. 736-750
Closed Access

Optimizing Liver Health Before and After Gene Therapy for Hemophilia A
Margaret V. Ragni, Henry Mead, Ype P. de Jong, et al.
Blood Advances (2024) Vol. 8, Iss. 19, pp. 5203-5212
Open Access | Times Cited: 3

Utilizing adeno‐associated virus as a vector in treating genetic disorders or human cancers
F.REDERICK F. SHIH, Hsiung‐Hao Chang, Yi‐Ching Wang
IUBMB Life (2024) Vol. 76, Iss. 12, pp. 1000-1010
Closed Access | Times Cited: 3

Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article
Jan Klapwijk, Alberto Del Rio Espinola, Silvana Libertini, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 15-16, pp. 527-542
Open Access | Times Cited: 3

UKHCDO gene therapy taskforce: Guidance for implementation of haemophilia gene therapy into routine clinical practice for adults
Pratima Chowdary, Beatriz Durán, Paul Batty, et al.
Haemophilia (2024)
Closed Access | Times Cited: 1

Current and Emerging Issues in Adeno-Associated Virus Vector-Mediated Liver-Directed Gene Therapy
Pasquale Piccolo, Nicola Brunetti‐Pierri
Human Gene Therapy (2024)
Closed Access | Times Cited: 1

Liver health in hemophilia in the era of gene therapy
Yesim Dargaud, Massimo Levrero, François Bailly, et al.
Thrombosis Research (2024) Vol. 240, pp. 109064-109064
Closed Access

Covalently linked adenovirus-AAV complexes as a novel platform technology for gene therapy
Logan Thrasher Collins, Wandy L. Beatty, Buhle Moyo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Genotoxicity evaluation of gene therapies: A report from the International Workshop on Genotoxicity Testing (IWGT) 2022
Silvana Libertini, Julie K. Jadlowsky, Thomas A. Lanz, et al.
Environmental and Molecular Mutagenesis (2024)
Closed Access

Modulation of AAV transduction and integration targeting by topoisomerase poisons
Aradhana Kasimsetty, Young Il Hwang, J.K. Everett, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101364-101364
Open Access

Page 1

Scroll to top